Description

1-(2-Chlorophenyl)-3-Phenyltetrahydro-1H-Thieno[3,4-D]Imidazol-2(3H)-One 5,5-Dioxide is a high-purity, advanced pharmaceutical intermediate characterized by its complex heterocyclic structure. This compound is of significant commercial value for its role in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring sophisticated molecular scaffolds. It is primarily sought by research institutions, custom synthesis organizations, and pharmaceutical companies engaged in the development of new chemical entities and proprietary drug candidates.

Application

• Pharmaceutical Intermediate: A key building block in the research and development of new drug candidates, especially for central nervous system (CNS) and metabolic disorder targets.
• Organic Synthesis Research: Used in academic and industrial laboratories for studying novel heterocyclic reactions and constructing complex molecular libraries.
• Custom Chemical Synthesis: Serves as a specialized starting material for contract research organizations (CROs) and CDMOs producing bespoke compounds for client projects.
• Precursor for Bioactive Molecules: Employed in the synthesis of molecules with potential pharmacological activity for screening and lead optimization.
• Chemical Reference Standard: Can be supplied as a high-purity standard for analytical method development and quality control in API manufacturing.

Basic Information

Product Name	1-(2-Chlorophenyl)-3-Phenyltetrahydro-1H-Thieno[3,4-D]Imidazol-2(3H)-One 5,5-Dioxide
CAS No.	537680-82-3
Molecular Formula	C19H15ClN2O3S
Molecular Weight	386.85 g/mol
Synonyms	1-(2-Chlorophenyl)-3-phenyltetrahydrothieno[3,4-d]imidazol-2(3H)-one 5,5-dioxide; Thieno[3,4-d]imidazol-2(3H)-one, 1-(2-chlorophenyl)-3-phenyltetrahydro-, 5,5-dioxide; Tetrahydro-1-(2-chlorophenyl)-3-phenyl-1H-thieno[3,4-d]imidazol-2(3H)-one 5,5-dioxide; 537680-82-3; Advanced heterocyclic sulfone intermediate; Chlorophenyl-phenyl thienoimidazolone dioxide.
EINECS	Contact for details

Quality Control

Our production of 1-(2-Chlorophenyl)-3-Phenyltetrahydro-1H-Thieno[3,4-D]Imidazol-2(3H)-One 5,5-Dioxide adheres to stringent quality management protocols. Every batch is subjected to comprehensive analytical testing, including HPLC for purity and identity confirmation via NMR and MS, to ensure it meets the exacting standards required for pharmaceutical R&D. A detailed Certificate of Analysis (COA) is provided with each shipment, guaranteeing traceability, consistency, and compliance with your specifications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed in a dry environment to prevent moisture absorption, which may affect stability and handling properties.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.